US Stock MarketDetailed Quotes

Jaguar Health (JAGX)

Watchlist

3.920
-0.020-0.51%

Close May 15 16:00 ET

3.760
-0.160-4.08%

Post 18:37 ET

1.46MMarket Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jaguar Health (JAGX) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

-1.52%11.51M

-7.81%3.24M

-0.80%3.08M

9.48%2.98M

-5.83%2.21M

19.75%11.69M

52.57%3.51M

10.49%3.11M

1.68%2.72M

19.22%2.35M

Operating revenue

-0.56%15.5M

-5.80%4.25M

1.22%4.07M

8.80%3.95M

-5.64%3.23M

14.53%15.58M

25.10%4.52M

8.94%4.02M

4.77%3.63M

20.26%3.42M

Cost of revenue

93.04%3.77M

294.97%2.2M

-1.66%532K

23.42%527K

19.77%515K

-4.03%1.96M

-18.92%557K

5.25%541K

-13.03%427K

24.64%430K

Gross profit

-20.52%7.74M

-64.94%1.04M

-0.62%2.55M

6.89%2.45M

-11.56%1.7M

26.02%9.73M

83.01%2.95M

11.66%2.57M

4.99%2.29M

18.07%1.92M

Operating expense

30.27%52.85M

93.33%21.48M

-0.41%9.79M

10.20%10.46M

9.71%11.12M

-2.59%40.57M

26.25%11.11M

-11.34%9.83M

-7.74%9.49M

-11.65%10.14M

Selling and administrative expenses

17.30%26.02M

12.06%5.31M

5.96%6.13M

23.23%7.19M

26.89%7.39M

-3.75%22.18M

-11.26%4.74M

15.60%5.79M

-2.86%5.84M

-13.04%5.82M

-Selling and marketing expense

1.83%4.17M

-23.31%1.47M

-11.95%737K

46.46%1.03M

87.59%1.24M

24.70%4.09M

131.60%1.91M

31.40%837K

-19.59%706K

-29.83%661K

-General and administrative expense

20.80%21.85M

36.04%3.84M

8.99%5.39M

20.03%6.16M

19.12%6.15M

-8.48%18.09M

-37.43%2.82M

13.30%4.95M

0.00%5.13M

-10.29%5.16M

Research and development costs

50.92%24.97M

215.68%14.31M

-9.52%3.66M

-10.62%3.27M

-13.50%3.73M

-11.05%16.54M

30.93%4.53M

-33.51%4.04M

-14.59%3.65M

-9.70%4.31M

Depreciation amortization depletion

0.98%1.86M

----

--1.84M

----

-Depreciation and amortization

0.98%1.86M

----

--1.84M

----

Operating profit

-46.31%-45.11M

-150.61%-20.44M

0.33%-7.24M

-11.25%-8.01M

-14.68%-9.42M

9.11%-30.83M

-13.51%-8.16M

17.36%-7.26M

11.17%-7.2M

16.56%-8.22M

Net non-operating interest income expense

71.00%-67K

-220.00%-132K

-103.70%-6K

-86.11%15K

109.17%56K

96.38%-231K

144.35%110K

132.40%162K

103.13%108K

71.99%-611K

Non-operating interest income

----

--56K

----

Non-operating interest expense

-71.00%67K

----

-96.38%231K

----

-71.99%611K

Total other finance cost

----

103.70%6K

86.11%-15K

----

-132.40%-162K

-103.13%-108K

----

Other net income (expense)

-7.73%-8.82M

-19.75%-2.62M

17.70%-2.4M

-1.14%-2.57M

-127.12%-1.23M

-412.13%-8.19M

-16.64%-2.19M

-311.21%-2.92M

-244.97%-2.54M

-46.09%-542K

Gain on sale of security

33.94%-6.27M

39.77%-1.55M

25.22%-2.31M

40.99%-1.07M

33.55%-1.34M

-85.07%-9.49M

-45.74%-2.57M

-37.66%-3.09M

-137.53%-1.81M

-462.95%-2.02M

Special income (charges)

-308.76%-2.6M

---777K

--0

---1.82M

--0

-62.57%1.25M

--0

--1.25M

-Less:Impairment of capital assets

--800K

----

--0

----

-Less:Other special charges

244.50%1.8M

---23K

----

--1.82M

----

66.32%-1.25M

--0

----

---1.25M

Other non- operating income (expenses)

-15.69%43K

-178.57%-297K

-155.95%-94K

144.17%322K

-52.14%112K

-74.50%51K

47.66%378K

340.00%168K

-2,903.85%-729K

2,050.00%234K

Income before tax

-37.57%-54M

-126.63%-23.19M

3.72%-9.65M

-9.68%-10.56M

-13.11%-10.6M

6.32%-39.25M

-9.94%-10.23M

-26.78%-10.02M

21.67%-9.63M

24.43%-9.37M

Income tax

Net income

-37.57%-54M

-126.63%-23.19M

3.72%-9.65M

-9.68%-10.56M

-13.11%-10.6M

6.32%-39.25M

-9.94%-10.23M

-26.78%-10.02M

21.67%-9.63M

24.43%-9.37M

Net income continuous Operations

-37.57%-54M

-126.63%-23.19M

3.72%-9.65M

-9.68%-10.56M

-13.11%-10.6M

6.32%-39.25M

-9.94%-10.23M

-26.78%-10.02M

21.67%-9.63M

24.43%-9.37M

Minority interest income

25.82%-563K

57.96%-132K

12.57%-146K

-12.50%-153K

7.04%-132K

-26.29%-759K

-125.90%-314K

-32.54%-167K

3.55%-136K

27.18%-142K

Net income attributable to the parent company

-38.82%-53.43M

-132.47%-23.06M

3.57%-9.5M

-9.64%-10.41M

-13.42%-10.46M

6.80%-38.49M

-8.18%-9.92M

-26.69%-9.85M

21.88%-9.49M

24.39%-9.23M

Preferred stock dividends

141K

Other preferred stock dividends

Net income attributable to common stockholders

-39.18%-53.58M

-133.89%-23.2M

3.57%-9.5M

-9.64%-10.41M

-13.42%-10.46M

6.80%-38.49M

-8.18%-9.92M

-26.69%-9.85M

21.88%-9.49M

24.39%-9.23M

Basic earnings per share

82.42%-803.95

82.28%-116.4005

76.11%-219.8

84.57%-359.1

80.83%-584.5

84.52%-4.57K

89.98%-657.0407

94.42%-920.15

93.03%-2.33K

92.43%-3.05K

Diluted earnings per share

82.42%-803.95

82.28%-116.4005

76.11%-219.8

84.57%-359.1

80.83%-584.5

84.52%-4.57K

89.98%-657.0407

94.42%-920.15

93.03%-2.33K

92.43%-3.05K

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	-1.52%11.51M	-7.81%3.24M	-0.80%3.08M	9.48%2.98M	-5.83%2.21M	19.75%11.69M	52.57%3.51M	10.49%3.11M	1.68%2.72M	19.22%2.35M
Operating revenue	-0.56%15.5M	-5.80%4.25M	1.22%4.07M	8.80%3.95M	-5.64%3.23M	14.53%15.58M	25.10%4.52M	8.94%4.02M	4.77%3.63M	20.26%3.42M
Cost of revenue	93.04%3.77M	294.97%2.2M	-1.66%532K	23.42%527K	19.77%515K	-4.03%1.96M	-18.92%557K	5.25%541K	-13.03%427K	24.64%430K
Gross profit	-20.52%7.74M	-64.94%1.04M	-0.62%2.55M	6.89%2.45M	-11.56%1.7M	26.02%9.73M	83.01%2.95M	11.66%2.57M	4.99%2.29M	18.07%1.92M
Operating expense	30.27%52.85M	93.33%21.48M	-0.41%9.79M	10.20%10.46M	9.71%11.12M	-2.59%40.57M	26.25%11.11M	-11.34%9.83M	-7.74%9.49M	-11.65%10.14M
Selling and administrative expenses	17.30%26.02M	12.06%5.31M	5.96%6.13M	23.23%7.19M	26.89%7.39M	-3.75%22.18M	-11.26%4.74M	15.60%5.79M	-2.86%5.84M	-13.04%5.82M
-Selling and marketing expense	1.83%4.17M	-23.31%1.47M	-11.95%737K	46.46%1.03M	87.59%1.24M	24.70%4.09M	131.60%1.91M	31.40%837K	-19.59%706K	-29.83%661K
-General and administrative expense	20.80%21.85M	36.04%3.84M	8.99%5.39M	20.03%6.16M	19.12%6.15M	-8.48%18.09M	-37.43%2.82M	13.30%4.95M	0.00%5.13M	-10.29%5.16M
Research and development costs	50.92%24.97M	215.68%14.31M	-9.52%3.66M	-10.62%3.27M	-13.50%3.73M	-11.05%16.54M	30.93%4.53M	-33.51%4.04M	-14.59%3.65M	-9.70%4.31M
Depreciation amortization depletion	0.98%1.86M	----	----	----	----	--1.84M	----	----	----	----
-Depreciation and amortization	0.98%1.86M	----	----	----	----	--1.84M	----	----	----	----
Operating profit	-46.31%-45.11M	-150.61%-20.44M	0.33%-7.24M	-11.25%-8.01M	-14.68%-9.42M	9.11%-30.83M	-13.51%-8.16M	17.36%-7.26M	11.17%-7.2M	16.56%-8.22M
Net non-operating interest income expense	71.00%-67K	-220.00%-132K	-103.70%-6K	-86.11%15K	109.17%56K	96.38%-231K	144.35%110K	132.40%162K	103.13%108K	71.99%-611K
Non-operating interest income	----	----	----	----	--56K	----	----	----	----	----
Non-operating interest expense	-71.00%67K	----	----	----	----	-96.38%231K	----	----	----	-71.99%611K
Total other finance cost	----	----	103.70%6K	86.11%-15K	----	----	----	-132.40%-162K	-103.13%-108K	----
Other net income (expense)	-7.73%-8.82M	-19.75%-2.62M	17.70%-2.4M	-1.14%-2.57M	-127.12%-1.23M	-412.13%-8.19M	-16.64%-2.19M	-311.21%-2.92M	-244.97%-2.54M	-46.09%-542K
Gain on sale of security	33.94%-6.27M	39.77%-1.55M	25.22%-2.31M	40.99%-1.07M	33.55%-1.34M	-85.07%-9.49M	-45.74%-2.57M	-37.66%-3.09M	-137.53%-1.81M	-462.95%-2.02M
Special income (charges)	-308.76%-2.6M	---777K	--0	---1.82M	--0	-62.57%1.25M	--0	--0	--0	--1.25M
-Less:Impairment of capital assets	--800K	----	----	----	----	--0	----	----	----	----
-Less:Other special charges	244.50%1.8M	---23K	----	--1.82M	----	66.32%-1.25M	--0	----	----	---1.25M
Other non- operating income (expenses)	-15.69%43K	-178.57%-297K	-155.95%-94K	144.17%322K	-52.14%112K	-74.50%51K	47.66%378K	340.00%168K	-2,903.85%-729K	2,050.00%234K
Income before tax	-37.57%-54M	-126.63%-23.19M	3.72%-9.65M	-9.68%-10.56M	-13.11%-10.6M	6.32%-39.25M	-9.94%-10.23M	-26.78%-10.02M	21.67%-9.63M	24.43%-9.37M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-37.57%-54M	-126.63%-23.19M	3.72%-9.65M	-9.68%-10.56M	-13.11%-10.6M	6.32%-39.25M	-9.94%-10.23M	-26.78%-10.02M	21.67%-9.63M	24.43%-9.37M
Net income continuous Operations	-37.57%-54M	-126.63%-23.19M	3.72%-9.65M	-9.68%-10.56M	-13.11%-10.6M	6.32%-39.25M	-9.94%-10.23M	-26.78%-10.02M	21.67%-9.63M	24.43%-9.37M
Minority interest income	25.82%-563K	57.96%-132K	12.57%-146K	-12.50%-153K	7.04%-132K	-26.29%-759K	-125.90%-314K	-32.54%-167K	3.55%-136K	27.18%-142K
Net income attributable to the parent company	-38.82%-53.43M	-132.47%-23.06M	3.57%-9.5M	-9.64%-10.41M	-13.42%-10.46M	6.80%-38.49M	-8.18%-9.92M	-26.69%-9.85M	21.88%-9.49M	24.39%-9.23M
Preferred stock dividends	141K
Other preferred stock dividends
Net income attributable to common stockholders	-39.18%-53.58M	-133.89%-23.2M	3.57%-9.5M	-9.64%-10.41M	-13.42%-10.46M	6.80%-38.49M	-8.18%-9.92M	-26.69%-9.85M	21.88%-9.49M	24.39%-9.23M
Basic earnings per share	82.42%-803.95	82.28%-116.4005	76.11%-219.8	84.57%-359.1	80.83%-584.5	84.52%-4.57K	89.98%-657.0407	94.42%-920.15	93.03%-2.33K	92.43%-3.05K
Diluted earnings per share	82.42%-803.95	82.28%-116.4005	76.11%-219.8	84.57%-359.1	80.83%-584.5	84.52%-4.57K	89.98%-657.0407	94.42%-920.15	93.03%-2.33K	92.43%-3.05K
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm